scholarly journals Histone deacetylase inhibitor treatment induces ‘BRCAness’ and synergistic lethality with PARP inhibitor and cisplatin against human triple negative breast cancer cells

Oncotarget ◽  
2014 ◽  
Vol 5 (14) ◽  
pp. 5637-5650 ◽  
Author(s):  
Kyungsoo Ha ◽  
Warren Fiskus ◽  
Dong Soon Choi ◽  
Srividya Bhaskara ◽  
Leandro Cerchietti ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Cells ◽  
Histone Deacetylase ◽  
Triple Negative Breast Cancer ◽  
Histone Deacetylase Inhibitor ◽  
Breast Cancer Cells ◽  
Triple Negative ◽  
Parp Inhibitor ◽  
Deacetylase Inhibitor ◽  
Inhibitor Treatment

scholarly journals Targeting triple-negative breast cancer cells with the histone deacetylase inhibitor panobinostat

2012 ◽  
Vol 14 (3) ◽  
Author(s):  
Chandra R Tate ◽  
Lyndsay V Rhodes ◽  
H Chris Segar ◽  
Jennifer L Driver ◽  
F Nell Pounder ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Cells ◽  
Histone Deacetylase ◽  
Triple Negative Breast Cancer ◽  
Histone Deacetylase Inhibitor ◽  
Breast Cancer Cells ◽  
Triple Negative ◽  
Deacetylase Inhibitor
Sign in / Sign up

Export Citation Format

Share Document